Table 3.

Team Process Measures across Three Trials (2012 to 2019)

Team Process MeasuresTrial 1 (n = 10 clinics)Trial 2 (n = 7)Trial 3 (n = 10)
Average # meetings (min, max)6.0 (3, 10)7.3 (2, 11)*n/a
Average # team hours (min, max)9.1 (2, 12)8.7 (2, 13)*n/a
Average # months from start to finish (min, max)3.0 (1, 7)7.7 (4, 15)n/a
Average # strategies selected (min, max)8.9 (3, 13)8.6 (1, 13)3.7 (3, 10)
# Strategies presented to each clinic to choose from151628
# Strategies related to regulatory compliance (%)32 (36)21 (35)4 (11)
# Strategies related to streamlining workflow (%)28 (31)19 (32)2 (5)
# Strategies related to providing peer support (%)20 (22)12 (20)30 (81)
# Strategies related to responding to patients at risk (%)9 (10)8 (13)1 (3)
  • * n = 6; one clinic did not report the number of team meetings held or hours of meetings held.

  • n/a, not available (these teams are currently still in process).